Santa Fe Fellows Workshop on Metabolic Bone Diseases
Hilton Santa Fe Historic Plaza, Santa Fe, New Mexico July 30-August 1, 2024
The Santa Fe Fellows Workshop on Metabolic Bone Diseases is a two-day preceptorial for fellows. It will precede the 24th Annual Santa Fe Bone Symposium, August 2-3, under the direction of the Osteoporosis Foundation of New Mexico. Drs. Michael McClung, John Bilezikian, and Michael Lewiecki lead the Fellows’ workshop which covers a broad spectrum of topics, including basic principles of bone metabolism, fracture risk assessment, an update of therapeutic approaches to osteoporosis, new guidelines for evaluation and therapy of primary hyperparathyroidism and hypoparathyroidism, as well as rare skeletal disorders such as hypophosphatasia, hypophosphatemia, and osteogenesis imperfecta. Faculty are internationally recognized in their field. Fellows are encouraged to submit an abstract to be presented at the Workshop. Four fellows will be selected to give oral presentations of their abstracts during the Santa Fe Bone Symposium.
Program Format:
The 2024 agenda is under development. The two-day interactive preceptorial features nineteen didactic lectures, five open discussion sessions for fellows and faculty to delve further into the presented topics, and fellow abstract presentations. Breakfast, lunch, and breaks will be provided each day. All fellows who participate in the workshop are invited to attend the 24th Annual Santa Fe Bone Symposium, August 2-3, 2024, in-person or remotely, with complimentary registration due to a scholarship from the Osteoporosis Foundation of New Mexico.
Faculty:
The faculty’s expertise extends to all facets of our field. This includes bone cell biology, bone biomechanics, histomorphometry of bone, and mechanisms of calciotropic hormone action. Their insights into the latest diagnostic and therapeutic approaches to osteoporosis, to other common and to rare metabolic bone diseases are at the forefront of the field, and in many instances, have been defined by their efforts.
- John P. Bilezikian, MD, PhD (hon), Silberberg Professor of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York
- Steven T. Harris, MD, FACP, FASBMR, Clinical Professor of Medicine, University of California, San Francisco
- E. Michael Lewiecki, MD, FACP, FACE, Director, New Mexico Clinical Research & Osteoporosis Center, Albuquerque, New Mexico
- Michael R. McClung, MD, Founding Director, Oregon Osteoporosis Center, Portland, Oregon
- Deborah Sellmeyer, MD, Clinical Professor of Medicine, Stanford University School of Medicine
- Andrea Singer, MD, FACP, CCD, Associate Professor and Chief, Division of Women’s Primary Care and Directory of Bone Densitometry, Department of Obstetrics and Gynecology, Georgetown University; Chief Medical Officer, National Osteoporosis Foundation, Washington, D.C
.jpeg)
Eligibility:Directors of Postdoctoral Subspecialty Training Programs for MDs are invited to identify individuals from their programs who meet the criteria and whose education would be enhanced by participating in this Workshop. The trainees can be from any subspecialties that deal with skeletal health (i.e., endocrinology, rheumatology, orthopedics, geriatrics, women’s health, etc.). The applicant must be in an accredited US-based, relevant specialty training program (1st, 2nd, or 3rd year)
Selected fellows will be notified by the end of May and those living outside the Santa Fe area will receive travel support and 3 nights hotel lodging at the program hotel.
Santa Fe Fellows Workshop 2024
Educational Support:This educational activity is supported by unrestricted educational grants from: Alexion, Amgen, Amolyt Pharma, Ascendis Pharma, and Radius.